Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A1c in individuals with well-controlled type 2 diabetes mellitus


      Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus. Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds, trials have not been conducted using a single serving of almonds (28 g) in individuals with type 2 diabetes mellitus. This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia, insulinemia, and plasma glucagon-like peptide–1 in healthy individuals and individuals with type 2 diabetes mellitus. On 2 occasions separated by at least 1 week, 19 adults (including 7 adults with type 2 diabetes mellitus) consumed a standardized evening meal and fasted overnight before ingesting the test meal (bagel, juice, and butter) with or without almonds. A small pilot study (6-7 subjects per group) was also conducted to observe whether chronic almond ingestion (1 serving 5 d/wk for 12 weeks) lowered hemoglobin A1c in individuals with type 2 diabetes mellitus. A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes (−30%, P = .043) but did not influence glycemia in participants without diabetes (−7%, P = .638). Insulinemia and glucagon-like peptide–1 at 30 minutes postmeal were not impacted by almond ingestion for either group. In the pilot study, regular almond ingestion for 12 weeks reduced hemoglobin A1c by 4% (P = .045 for interaction) but did not influence fasting glucose concentrations. These data show that modest almond consumption favorably improves both short-term and long-term markers of glucose control in individuals with uncomplicated type 2 diabetes mellitus.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Li T.Y.
        • Brennan A.M.
        • Wedick N.M.
        • et al.
        Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes.
        J Nutr. 2009; 139: 1333-1338
        • Hu F.B.
        • Stampfer M.J.
        Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence.
        Curr Atheroscler Rep. 1999; 1: 204-209
        • Jiang R.
        • Manson J.E.
        • Stampfer M.J.
        • et al.
        Nut and peanut butter consumption and risk of type 2 diabetes in women.
        J Am Med Assoc. 2002; 288: 2554-2560
        • Kochar J.
        • Gaziano J.M.
        • Djousse L.
        Nut consumption and risk of type II diabetes in the Physicians' Health Study.
        Eur J Clin Nutr. 2010; 64: 75-79
        • Parker E.D.
        • Harnack L.J.
        • Folsom A.R.
        Nut consumption and risk of type 2 diabetes.
        J Am Med Assoc. 2003; 290: 38-39
        • Lovejoy J.C.
        • Most M.M.
        • Lefevre M.
        • et al.
        Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes.
        Am J Clin Nutr. 2002; 76: 1000-1006
        • Tapsell L.C.
        • Batterham M.J.
        • Teuss G.
        • et al.
        Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes.
        Eur J Clin Nutr. 2009; 63: 1008-1015
        • Jenkins D.J.A.
        • Kendall C.W.C.
        • Josse A.R.
        • et al.
        Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals.
        J Nutr. 2006; 136: 2987-2992
        • Josse A.R.
        • Kendall C.W.C.
        • Augustin L.S.A.
        • et al.
        Almonds and postprandial glycemia—a dose-response study.
        Metab Clin Exp. 2007; 56: 400-404
        • Cassady B.A.
        • Hollis J.H.
        • Fulford A.D.
        • et al.
        Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response.
        Am J Clin Nutr. 2009; 89: 794-800
        • Vollmer K.
        • Holst J.J.
        • Baller B.
        • et al.
        Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
        Diabetes. 2008; 57: 678-687
        • Aydin S.
        A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics.
        J Biochem Mol Biol. 2007; 40: 29-35
        • Dodds M.W.
        • Dodds A.P.
        Effects of glycemic control on saliva flow rates and protein composition in non–insulin-dependent diabetes mellitus.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 83: 465-470
        • Yavuzyilmaz E.
        • Yumak O.
        • Akdoğanli T.
        • et al.
        The alterations of whole saliva constituents in patients with diabetes mellitus.
        Aust Dent J. 1996; 41: 193-197
        • Skude G.
        • Ihse I.
        Salivary amylase in duodenal aspirates.
        Scand J Gastroenterol. 1976; 11: 17-20
        • Kawamori R.
        • Katsura M.
        • Ishida S.
        • et al.
        Subclinical exocrine pancreatic derangement in human diabetic patients evaluated from pure pancreatic juice.
        J Diabetes Complications. 1995; 9: 69-73
        • Lo Piparo E.
        • Scheib H.
        • Frei N.
        • et al.
        Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
        J Med Chem. 2008; 51: 3555-3561
        • Milbury P.E.
        • Chen C.Y.
        • Dolnikowski G.G.
        • et al.
        Determination of flavonoids and phenolics and their distribution in almonds.
        J Agric Food Chem. 2006; 54: 5027-5033
        • Li S.C.
        • Liu Y.H.
        • Liu J.F.
        • et al.
        Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus.
        Metabolism. 2010; ([Epub ahead of print])
        • Wien M.
        • Bleich D.
        • Raghuwanshi M.
        • et al.
        Almond consumption and cardiovascular risk factors in adults with prediabetes.
        J Am Coll Nutr. 2010; 29: 189-197
        • Bode B.W.
        Defining the importance of daily glycemic control and implications for type 2 diabetes management.
        Postgrad Med. 2009; 121: 82-93
        • Kohnert K.D.
        • Augstein P.
        • Heinke P.
        • et al.
        Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes.
        Diabetes Res Clin Pract. 2007; 77: 420-426
        • Heine R.J.
        • Balkau B.
        • Ceriello A.
        • et al.
        What does postprandial hyperglycaemia mean?.
        Diabet Med. 2004; 21: 208-213
        • Banel D.K.
        • Hu F.B.
        Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review.
        Am J Clin Nutr. 2009; 90: 56-63
        • White J.
        Efficacy and safety of incretin based therapies: clinical trial data.
        J Am Pharm Assoc. 2009; 49: S30-S40
        • Göke B.
        • German Pioglitazone Study Group
        Improved glycemic control and lipid profile in a randomized study of pioglitazone compared with acarbose in patients with type 2 diabetes mellitus.
        Treat Endocrinol. 2002; 1: 329-336
        • Hanefeld M.
        • Chiasson J.L.
        • Koehler C.
        • et al.
        Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.
        Stroke. 2004; 35: 1073-1078
        • Zeymer U.
        • Schwarzmaier-D'assie A.
        • Petzinna D.
        • et al.
        Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy.
        Eur J Cardiovasc Prev Rehabil. 2004; 11: 412-415
        • Brennan A.M.
        • Sweeney L.L.
        • Liu X.
        • et al.
        Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period.
        Obesity (Silver Spring). 2010; 18: 1176-1182
        • Toft-Nielsen M.B.
        • Damholt M.B.
        • Madsbad S.
        • et al.
        Determinants of the impaired secretion of glucagon-like peptide–1 in type 2 diabetic patients.
        J Clin Endocrinol Metab. 2001; 86: 3717-3723
        • Kris-Etherton P.M.
        • Pearson T.A.
        • Wan Y.
        • et al.
        High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations.
        Am J Clin Nutr. 1999; 70: 1009-1015
        • Cheng A.Y.Y.
        • Leiter L.A.
        Glucose lowering and cardiovascular disease: what do we know and what should we do?.
        Eur J Cardiovasc Prev Rehabil. 2010; 17: S25-S31